Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S (PFE) Price & Analysis

6 Followers

PFE Stock Chart & Stats

C$12.66

C$0.26(2.23%)

At close: Aug 07 4:00 PM EDT

C$12.66

C$0.26(2.23%)

Day’s Range― - ―

52-Week RangeC$10.57 - C$13.00

Previous CloseN/A

Volume131.32K

Average Volume (3M)113.77K

Market Cap

C$221.37B

Enterprise ValueC$135.61K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)36.7

Beta0.41

Next Earnings

Nov 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield6.23%

Share Statistics

EPS (TTM)-0.06

Shares Outstanding5,699,674,000

10 Day Avg. Volume50,216

30 Day Avg. Volume113,771

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S News

Pfizer CEO Bourla plans to attend White House state dinner, Reuters reports

Pfizer (PFE) CEO Albert Bourla is expected to attend President Trump’s September 24 state dinner for Chinese President...

9h ago

Trump Trade: U.S. announces deal with Denmark over Greenland’s security

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...

1d ago

AZN

BMY

Pfizer to share portion of increased revenue to U.S. HHS, Bloomberg says

The U.S. Department of Health and Human Services, HHS, will receive a portion of the increased revenue if...

2d ago

PFE

U.S. weighs allowing most pharma licensing deals with China, Reuters says

The U.S. is working on rules for pharmaceutical companies investing in China that would likely preserve their ability...

4d ago

AZN

BMY

Health Canada authorizes Pfizer, BioNTech’s Omicron XFG-adapted Covid-19 vaccine

Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the XFG variant-adapted COMIRNATY for active...

5d ago

PFE

BNTX

Pfizer aims at air-traffic controllers for Covid-19 vaccine money, WSJ says

In an attempt to get paid for millions of unwanted Covid-19 vaccines, Pfizer (PFE) is taking aim at...

9d ago

PFE

Pfizer price target raised to $30 from $28 at HSBC

HSBC raised the firm’s price target on Pfizer (PFE) to $30 from $28 and keeps a Hold rating...

13d ago

PFE

Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer

Vaxcyte (PCVX) announced the appointments of Luis Jodar as chief medical officer and David McAvoy as chief legal...

19d ago

PFE

PCVX

Trump Trade: U.S. nearing deal for Venezuelan oil field stake

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...

25d ago

COP

U.S. companies work to gain favor with Democrats, WSJ reports

Some U.S. companies with close ties to President Trump are trying to gain favor with Democrats in case...

26d ago

CVX

PFE

Pfizer: Improving Fundamentals and Cost Savings Offset by Pipeline Execution Risks; Hold Rating Reiterated with Unchanged $28 Price Target

Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Pfizer, retaining the price target of $28.00....

2M ago

PFE

Pfizer: Hold Rating Reaffirmed as COVID Headwinds Persist and 12‑Month Price Target Remains Unchanged at $26

Goldman Sachs analyst Asad Haider maintained a Hold rating on Pfizer yesterday and set a price target of...

2M ago

PFE

Pfizer: Mixed Q2 Update and Limited Long‑Term Visibility Keep Hold Rating as Price Target Nudged Up to $27

Jason Gerberry, an analyst from Bank of America Securities, reiterated the Hold rating on Pfizer. The associated price...

2M ago

PFE

Pfizer: Hold Rating Reiterated as Analyst Keeps $28 Price Target Unchanged Amid Balanced Pipeline Prospects and LOE Headwinds

In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer, with a...

2M ago

PFE

PFE FAQ

What was Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s price range in the past 12 months?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S lowest stock price was C$10.57 and its highest was C$13.00 in the past 12 months.

What is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s market cap?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s market cap is C$221.37B.

When is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s upcoming earnings report date?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s upcoming earnings report date is Nov 03, 2026 which is in 41 days.

How were Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s earnings last quarter?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S released its earnings results on Aug 04, 2026. The company reported -C$0.06 earnings per share for the quarter.

Is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S overvalued?

According to Wall Street analysts Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S pay dividends?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S pays a Quarterly dividend of C$0.191 which represents an annual dividend yield of 6.23%. See more information on Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S dividends here

What is Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s EPS estimate?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S have?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S has 5,699,674,000 shares outstanding.

What happened to Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S’s price movement after its last earnings report?

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S reported an EPS of -C$0.06 in its last earnings report. Following the earnings report the stock price went up 0.98%.

Which hedge fund is a major shareholder of Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S?

Currently, no hedge funds are holding shares in TSE:PFE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S Stock Smart Score

Neutral

News Sentiment

Very Bullish

Bullish news 100%
Bearish news 0%

Fundamentals

Return on Equity

6.23%

Trailing 12-Months

Asset Growth

1.47%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.